CD44 and cancer: In summary, X-NP-DOX as novel drug-delivery system could effectively target at BC cells via binding to CD44 molecular, and suppress cancer cells growth, inhibit migration and invasion, induce apoptosis, and reduce population of CSCs even at low dose owing to increased DOX distribution in cellular through endocytosis.